333 related articles for article (PubMed ID: 8367738)
21. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
[TBL] [Abstract][Full Text] [Related]
22. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
Nilsson IM
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
[TBL] [Abstract][Full Text] [Related]
23. [New viewpoints in the treatment of hemophilia].
Göbel U
Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
[No Abstract] [Full Text] [Related]
24. Secondary prophylaxis in an adult patient with severe haemophilia A. Factor VIII consumption and effectiveness.
Schlenkrich S; Schubert C
Hamostaseologie; 2013 Aug; 33(3):241-4. PubMed ID: 23435748
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness--can it be measured?
Bohn RL; Avorn J
Semin Hematol; 1993 Jul; 30(3 Suppl 2):20-3. PubMed ID: 8367739
[No Abstract] [Full Text] [Related]
26. A guide for home treatment--Madrid 1978.
Scand J Haematol Suppl; 1980; 35():1-27. PubMed ID: 6770457
[No Abstract] [Full Text] [Related]
27. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Manco-Johnson MJ; Abshire TC; Shapiro AD; Riske B; Hacker MR; Kilcoyne R; Ingram JD; Manco-Johnson ML; Funk S; Jacobson L; Valentino LA; Hoots WK; Buchanan GR; DiMichele D; Recht M; Brown D; Leissinger C; Bleak S; Cohen A; Mathew P; Matsunaga A; Medeiros D; Nugent D; Thomas GA; Thompson AA; McRedmond K; Soucie JM; Austin H; Evatt BL
N Engl J Med; 2007 Aug; 357(6):535-44. PubMed ID: 17687129
[TBL] [Abstract][Full Text] [Related]
28. Update on treatment regimens: prophylaxis versus on-demand therapy.
Manco-Johnson MJ
Semin Hematol; 2003 Jul; 40(3 Suppl 3):3-9. PubMed ID: 14690062
[TBL] [Abstract][Full Text] [Related]
29. [The situation of hemophiliacs in Sweden].
Nilsson IM
Lakartidningen; 1981 Dec; 78(52):4725-8. PubMed ID: 6799720
[No Abstract] [Full Text] [Related]
30. Central venous access devices in children with hemophilia: an update.
Blanchette VS; Al-Musa A; Stain AM; Ingram J; Fille RM
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S11-4. PubMed ID: 9351530
[TBL] [Abstract][Full Text] [Related]
31. [Experience from the Hemophilia Clinic. 3. Intramuscular hemorrhages in hemophilia].
van Creveld S; Mochtar IA; van Donk H
Ned Tijdschr Geneeskd; 1970 Apr; 114(17):719-22. PubMed ID: 5444639
[No Abstract] [Full Text] [Related]
32. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
34. Prophylaxis re-visited: The potential impact of novel factor and non-factor therapies on prophylaxis.
Carcao M; Lambert T; Leissinger C; Escuriola-Ettingshausen C; Santagostino E; Aledort L;
Haemophilia; 2018 Nov; 24(6):845-848. PubMed ID: 29989273
[No Abstract] [Full Text] [Related]
35. [Substitution treatment in hemophilia. Critical measures and complications].
Schimpf K
Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
[No Abstract] [Full Text] [Related]
36. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Steen Carlsson K; Höjgård S; Glomstein A; Lethagen S; Schulman S; Tengborn L; Lindgren A; Berntorp E; Lindgren B
Haemophilia; 2003 Sep; 9(5):555-66. PubMed ID: 14511294
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.
van den Berg HM; Fischer K; Mauser-Bunschoten EP; Beek FJ; Roosendaal G; van der Bom JG; Nieuwenhuis HK
Br J Haematol; 2001 Mar; 112(3):561-5. PubMed ID: 11260054
[TBL] [Abstract][Full Text] [Related]
38. Dosage requirements for substitution therapy in hemophiliacs.
Scand J Haematol Suppl; 1980; 35():29-54. PubMed ID: 6770459
[No Abstract] [Full Text] [Related]
39. [Prevention of handicapping hemorrhagic complications in severe and moderate hemophilia].
Landbeck G; Kurme A
Med Welt; 1973 May; 24(19):763-8. PubMed ID: 4720575
[No Abstract] [Full Text] [Related]
40. The management of deep soft tissue bleeding and hemarthrosis in hemophilia.
Miller EH; Flessa HC; Glueck HI
Clin Orthop Relat Res; 1972; 82():92-107. PubMed ID: 5011042
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
